This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Momenta Pharmaceuticals, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Hong Sun and His Patent in FcRn Antibody Research.
Introduction
Hong Sun is an inventor associated with Spring House, Pennsylvania, and Momenta Pharmaceuticals, Inc. His patent work concerns antibodies targeting FcRn and methods for treating myasthenia gravis.
Latest Patents
Sun is listed on 1 patent: “Anti-FcRn Antibodies and Methods for Treating Myasthenia Gravis.” The patent focuses on antibody-based approaches related to treatment of the autoimmune disorder.
Career Highlights
Sun’s listed invention connects his work with Momenta Pharmaceuticals to research into FcRn-targeting therapies. The patent record identifies him as an inventor on this work.
Collaborations
Sun’s listed coworkers include Sindhu Ramchandren and William Denney.
Conclusion
Hong Sun’s patent activity reflects a contribution to FcRn antibody research and potential therapeutic approaches for myasthenia gravis.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile